arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Nutex Health Inc.

NUTX
$201.74 ▼ -6.73 (-3.23%) at close
Industrials ·Services-Business Services, NEC ·USServices-Business Services, NEC
62 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
86
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Nutex Health Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.4B
Dividend Yield —
Revenue Growth -13.6% ↘
Op. Margin 57.8% ↗
ROIC 23.5% ↗
FCF / Share $4.61 ↘
Trailing P/E 21.1x
Price / Book 3.5x
FCF Yield 2.3%
Debt / Equity 0.08
info Valuation on last close. End-of-day price, Sep 23, 2026.

62-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$210.75M
↓ -13.6% —
Net Income Profit after all expenses
$65.84M
↑ +40.7% —
Operating Margin Operating profit as % of sales
57.8%
↑ +53.9% 87th
FCF / Share Free cash flow per share
$4.61
↓ -56.7% —
Long-Term Debt Long-term obligations
$31.11M
↑ +28.2% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
79
Returns ↓
88
Financial Health →
89
Cash Quality ↑
93

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 15 years · 62 quarters